NLRP3 and cardiac hypertrophy: Recently, NLRP3 inflammasome activation in cardiomyocytes has received increasing attention because its inhibition significantly attenuates pressure overload‐induced cardiac hypertrophy, fibrosis, and cardiac dysfunction.14, 15